Nvidia launched a $500 billion financing platform while simultaneously facing scrutiny from Wall Street over its deal structure and risk distribution mechanisms. The financing effort comes alongside technical developments including cross-vendor LLM inference compatibility and partnerships with AI companies like Perplexity. For healthcare AI deployments, this matters because financing terms directly impact infrastructure procurement costs for hospitals and health systems building LLM-based clinical tools. The credit risk allocation model Nvidia establishes will influence how healthcare organizations budget for AI infrastructure, particularly relevant as more health systems pursue vendor-agnostic deployment strategies. Healthcare IT leaders should monitor these financing structures as they evaluate capital expenditure options for generative AI in clinical workflows and EHR integration projects.